GlassScriptPhysician profile
Katia Ilieva
NPI 1821195603
$2,403.61
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $221 · 2021: $2,039 · 2022: $143.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $341.03 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $267.17 | 2020-2022 | |
| Abbvie INC. | $220.87 | 2021-2022 | |
| Amgen INC. | $203.67 | 2020-2021 | |
| Ibsa Pharma INC. | $122.96 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.57 | 2020-2022 | |
| Vanda Pharmaceuticals INC. | $98.44 | 2021 | |
| Pfizer INC. | $93.62 | 2020-2021 | |
| Lilly USA, LLC | $81.51 | 2021 | |
| Glaxosmithkline, LLC. | $80.61 | 2021 | |
| Esperion Therapeutics, INC. | $63.84 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.16 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $58.44 | 2021 | |
| Novartis Pharmaceuticals Corporation | $55.47 | 2021 | |
| Mylan Specialty L.P. | $51.80 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $50.75 | 2021 | |
| Jazz Pharmaceuticals INC. | $46.72 | 2021 | |
| Biogen, INC. | $44.81 | 2021 | |
| Daiichi Sankyo INC. | $43.61 | 2021 | |
| Amarin Pharma, INC. | $43.24 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.76 | 2021 | |
| Arbor Pharmaceuticals, INC. | $36.00 | 2021 | |
| Sunovion Pharmaceuticals INC. | $29.67 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $28.67 | 2021 | |
| Dexcom, INC. | $24.92 | 2021 | |
| Nestle Healthcare Nutrition INC. | $24.91 | 2020 | |
| Astellas Pharma US INC | $24.59 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.35 | 2021 | |
| Hologic Sales and Service, LLC | $17.43 | 2021 | |
| Merck Sharp & Dohme LLC | $14.36 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.66 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katia Ilieva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.